(Q38362089)

2 September 2017

0 references

1 reference

title

Zinc in Alzheimer's Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies (English)

1 reference

2 September 2017

0 references

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25697706%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Mariacristina Siotto

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25697706%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Rosanna Squitti

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25697706%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

4

Stefania Mariani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25697706%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Mariacarla Ventriglia

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25697706%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

George J Brewer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25697706%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Serena Bucossi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25697706%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

publication date

19 February 2015

1 reference

Journal of Alzheimer's Disease

2 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25697706%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25697706%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25697706%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

75-87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25697706%20AND%20SRC:MED&resulttype=core&format=json

Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives.

3 June 2020

cites work

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Elevated labile Cu is associated with oxidative pathology in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Is cognitive function linked to serum free copper levels? A cohort study in a normal population.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Excess of serum copper not related to ceruloplasmin in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF [beta]-amyloid, and h-tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Value of serum nonceruloplasmin copper for prediction of mild cognitive impairment conversion to Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Regulation of metallothionein genes by heavy metals appears to be mediated by a zinc-sensitive inhibitor that interacts with a constitutively active transcription factor, MTF-1

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Metal swap between Zn7-metallothionein-3 and amyloid-beta-Cu protects against amyloid-beta toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Potential blood biomarker for disease severity in the Taiwanese population with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Zinc and thymic hormone-dependent immunity in normal ageing and in patients with senile dementia of the Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Serum zinc levels and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Serum aluminium and zinc and other variables in patients with and without cognitive impairment in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Homeostasis of metals in the progression of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Characterization of metal profiles in serum during the progression of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Serum chemical elements and oxidative status in Alzheimer's disease, Parkinson disease and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Estimating the mean and variance from the median, range, and the size of a sample

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Decreased serum zinc is an effect of ageing and not Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Serum multivalent cationic pattern: speculation on the efficient approach for detection of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Determination of selected trace elements in patients affected by dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Serum zinc is decreased in Alzheimer's disease and serum arsenic correlates positively with cognitive ability

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Lower serum zinc in major depression in relation to changes in serum acute phase proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Evaluation of a prototype point-of-care instrument based on monochromatic x-ray fluorescence spectrometry: potential for monitoring trace element status of subjects with neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Cerebrospinal fluid trace element content in dementia: clinical, radiologic, and pathologic correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Patterns of levels of biological metals in CSF differ among neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

CSF zinc in Alzheimer's type dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Zinc homeostasis and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Dietary supplementation and quality of life of older patients: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Zinc diet and Alzheimer's disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Effect of multivitamin and multimineral supplementation on cognitive function in men and women aged 65 years and over: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Diet and Alzheimer’s disease risk factors or prevention: the current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Micronutrients supplementation and nutritional status in cognitively impaired elderly persons: a two-month open label pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Cognitive function in healthy older European adults: the ZENITH study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Zinc status, psychological and nutritional assessment in old people recruited in five European countries: Zincage study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Low-copper diet as a preventive strategy for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Dietary copper and high saturated and trans fat intakes associated with cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Wilson's disease and other neurological copper disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

The risks of copper toxicity contributing to cognitive decline in the aging population and to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Copper toxicity in Alzheimer's disease: cognitive loss from ingestion of inorganic copper

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Copper excess, zinc deficiency, and cognition loss in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Paradigm shift in treatment of Alzheimer's disease: zinc therapy now a conscientious choice for care of individual patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Anti-copper therapies in Alzheimer's disease: new concepts.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

d-penicillamine reduces serum oxidative stress in Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Treatment of Wilson's disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientine

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Hypocupremia associated cytopenia and myelopathy: a national retrospective review

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Lipid peroxidation and free radical scavengers in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296

Subclinical zinc deficiency in Alzheimer's disease and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-141296